The findings are promising, but need to be replicated in a larger sample and expanded upon, senior study author Dr. Ed Goetzl told TIME. He and his team are looking at other proteins as well. “My vision of the future is you have your breakfast cereal, and on one side you have a statin for cardiovascular disease, and on the other side you have three pills to prevent dementia,” he says. “What I can see in this disease process is it’s far too complicated for a single magic bullet. The reason we’re trying to mine all these different pathogenic mechanisms is because I think they’re going to have to have at least two or maybe three targets against which a drug is directed.”